| Literature DB >> 35855103 |
Maghroori Razie1, Karshenas Leila1, Khosrawi Saied1.
Abstract
BACKGROUND: Iliotibial band syndrome (ITBS) is a common leading cause of lateral knee pain. Despite varieties of medical and non-medical treatments proposed for the management of ITBS, the best therapeutic approach for its treatment remained a significant question. The current study aims to compare the outcomes of dry needling (DN) versus shockwave therapy (SWT) in the management of ITBS.Entities:
Keywords: Dry Needling; Extracorporeal Shockwave Therapy; Iliotibial Band Syndrome; Pain
Year: 2021 PMID: 35855103 PMCID: PMC9260514 DOI: 10.31661/gmj.v10i0.2174
Source DB: PubMed Journal: Galen Med J ISSN: 2322-2379
Figure 1The Comparison of the Demographic Information Between the Studied Groups.
| Variables | Groups | P-value | |
| Dry needling (n=20) | Shockwave (n=20) | ||
| Gender, n (%) | |||
| Female | 15±75 | 15±75 | >0.999* |
| Male | 5±25 | 5±25 | |
| Age, mean±SD | 49.1±12.31 | 54.55±16.52 | 0.24** |
| Body mass index, mean±SD | 26.68±3.47 | 25.25±3.76 | 0.22** |
| Duration of the ITBS, mean±SD | 22±34.58 | 11.7±19.88 | 0.11£ |
* Fisher's Exact Test; ** T-test; £ Mann-Whitney
The Comparison of Pain Severity, LEFS, and ITBL Between the Studied Groups.
| Variables | Dry needling (n=20) | Shockwave (n=20) | P-value |
| Means± SD | |||
| Pain | |||
| Baseline | 8.95±1.14 | 8.3±1.83 | 0.38* |
| Immediately by the intervention cessation | 3.05±2.08 | 3.8±2.39 | 0.39* |
| Within four weeks after the intervention | 1.75±1.77 | 3.6±2.68 | 0.023* |
| P-value** | <0.001 | <0.001 | |
| Lower Extremity Function | |||
| Baseline | 34.9±16.6 | 38.65±12.52 | 0.42δ |
| Immediately by the intervention cessation | 55.15±17.86 | 47.9±14.03 | 0.16δ |
| Within four weeks after the intervention | 54.9±17.77 | 49.7±14.14 | 0.31δ |
| P-value£ | <0.001 | <0.001 | |
| Length of ITB | |||
| Baseline | 26.35±5.67 | 24.4±6.78 | 0.56 |
| Immediately by the intervention cessation | 25.7±6.13 | 25.2±5.95 | 0.86 |
| Within four weeks after the intervention | 25.9±6.01 | 25.75±4.71 | 0.79 |
| P-value** | 0.93 | 0.75 |
* Mann-Whitney; ** GEE; δ Independent t-test; £ Repeated Measure ANOVA